Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis

Journal of Neuroimmune Pharmacology

Volumn 7, Issue 3, 2012, Pages 686-700

  Gelman, Benjamin B ^a   Lisinicchia, Joshua G ^a   Chen, Tianshen ^a   Johnson, Kenneth M ^a   Jennings, Kristofer ^b   Freeman, Daniel H ^b   Soukup, Vicki M ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Dopamine receptor; Enkephalin; HAND; HIV associated neurocognitive disorders; HIVE; HIVencephalitis; Interferon regulatory factor; Opiate; Opioid; Synaptic plasticity

Indexed keywords

DOPAMINE 2 RECEPTOR; INTERFERON REGULATORY FACTOR 1; MESSENGER RNA; PREPROENKEPHALIN;

ADULT; ARTICLE; ATTENTION; AUTOPSY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; DOWN REGULATION; ENKEPHALINERGIC SYSTEM; EXECUTIVE FUNCTION; HEPATITIS C; HIV ASSOCIATED DEMENTIA; HIV ASSOCIATED ENCEPHALITIS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LEARNING; NERVE CELL PLASTICITY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ISOLATION; SUBSTANCE ABUSE; SYNAPTIC TRANSMISSION; WORKING MEMORY;

ADULT; AIDS DEMENTIA COMPLEX; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COGNITION DISORDERS; ENCEPHALITIS; ENKEPHALINS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PREFRONTAL CORTEX; PROTEIN PRECURSORS; RECEPTORS, DOPAMINE D2; SYNAPSES;

EID: 84866096031     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-012-9345-4     Document Type: Article

References (148)

1. Achim CL, Wang R, Miners DK, Wiley CA (1994) Brain viral burden in HIV infection. J Neuropathol Exp Neurol 53(3):284-294 (Pubitemid 24146867)
2. Albensi BC, Mattson MP (2000) Evidence for the involvement of TNF and NF-κB in hippocampal synaptic plasticity. Synapse 35 (2):151-159 (Pubitemid 30036192)
3. Angulo JA, Coirini H, Ledoux M, Schumacher M (1991) Regulation by dopaminergic neurotransmission of dopamine D2 mRNA and receptor levels in the striatum and nucleus accumbens of the rat. Brain Res Mol Brain Res 11(2):161-166
4. Antinori A, Arendt G, Becker JT et al (2007) Updated research nosology for HIV-Associated neurocognitive disorders. Neurology 69 (18):1789-1799 (Pubitemid 350059308)
5. Antonini A, Leenders KL, Reist H, Thomann R, Beer HF, Locher J (1993) Effect of age on D2 dopamine receptors in normal human brain measured by positron emission tomography and 11Craclopride. Arch Neurol 50(5):474-80 (Pubitemid 23143137)
6. Baddeley A (2003) Working memory: Looking back and looking forward. Nat Rev Neurosci 4(10):829-839 (Pubitemid 37314405)
7. Benjamini Y, Yekutieli D (2001) The control of the false discovery rate in multiple testing under dependency. Ann Stat 29(4):1165-1188 (Pubitemid 33575263)
8. Berger JR, Arendt G (2000) HIV dementia: The role of the basal ganglia and dopaminergic systems. J Psychopharmacol 14(3):214-221
9. Berger-Greenstein JA, Cuevas CA, Brady SM, Trezza G, Richardson MA, Keane TM (2007) Major depression in patients with HIV/ AIDS and substance abuse. AIDS Patient Care STDS 21 (12):942-955
10. Boehm U, Klamp T, Groot M, Howard JC (1997) Cellular responses to interferon-gamma. Ann Rev Immunol 15:749-795
11. Boulanger LM (2004) MHC class I in activity-dependent structural and functional plasticity. Neuron Glia Biol 1(3):283-289
12. Boulanger LM (2009) Immune proteins in brain development and synaptic plasticity. Neuron 64(1):93-109
13. Boulanger LM, Huh GS, Shatz CJ (2001) Neuronal plasticity and cellular immunity: Shared molecular mechanisms. Curr Opin Neurobiol 11(5):568-578 (Pubitemid 32938288)
14. Brask J, Kristensson K, Hill RH (2004) Exposure to interferon-γ during synaptogenesis increases inhibitory activity after a latent period in cultured rat hippocampal neurons. Eur J Neurosci 19(12):3193-3201 (Pubitemid 38859536)
15. Budka H, Wiley CA, Kleihues P et al (1991) HIV-Associated disease of the nervous system: Review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol 1(3):143-152
16. Chang L,Wang GJ, Volkow ND, Ernst T, Telang F, Logan J, Fowler JS (2008) Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse. Neuroimage 42:869-878
17. Citri A, Malenka RC (2008) Synaptic plasticity: Multiple forms, functions, and mechanisms. Neuropsychopharmacology 33(1):18-41 (Pubitemid 350191314)
18. Clifford DB, Evans SR, Yang Y et al (2005) The neuropsychological and neurological impact of hepatitis C virus co-infection in HIVinfected subjects. AIDS 19(Suppl 3):S64-S71 (Pubitemid 41682171)
19. Cohen JD, Servan-Schreiber D (1992) Context, cortex, and dopamine: A connectionist approach to behavior and biology in schizophrenia. Psychol Rev Jan 99(1):45-77
20. Cohen JD, Braver TS, Brown JW (2002) Computational perspectives on dopamine function in prefrontal cortex. Curr Opin Neurobiol 12(2):223-229 (Pubitemid 34518344)
21. Cools R, D'Esposito M(2011) Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry 69(12):113-125
22. Cunningham AJ, Murray CA, O'Neill LA et al (1996) Interleukin-1β (IL-1β) and tumour necrosis factor (TNF) inhibit long-Term potentiation in the rat dentate gyrus in vitro. Neurosci Lett 203 (1):17-20
23. D'Arcangelo G, Grassi F, Ragozzino D, Santoni A, Tancredi V, Eusebi F (1991) Interferon inhibits synaptic potentiation in rat hippocampus. Brain Res 564(2):245-248
24. Da Cunha A, Rausch DM, Eiden LE (1995) An early increase in somatostatin mRNA expression in the frontal cortex of rhesus monkeys infected with simian immunodeficiency virus. Proc Natl Acad Sci USA 92(5):1371-1375
25. Dafny N (1998) Is interferon-Alpha a neuromodulator? Brain Res Brain Res Rev 26(1):1-15
26. Dafny N, Yang PB (2005) Interferon and the central nervous system. Eur J Pharmacol 523:1-15 (Pubitemid 41562371)
27. Dafny N, Prieto-Gomez B, Dong WQ, Reyes-Vazquez C (1996) Interferon modulates neuronal activity recorded from the hypothalamus, thalamus, hippocampus, amygdala and the somatosensory cortex. Brain Res 734(1-2):269-274 (Pubitemid 26334055)
28. De Vries TJ, Shippenberg TS (2002) Neural systems underlying opiate addiction. J Neurosci 22(9):3321-3325 (Pubitemid 37465735)
29. Delhaye S, Paul S, Gjon B, Minet M, Weber F, Staeheli P, Michiels T (2006) Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci USA 103(20):7835-7840
30. Di Filippo M, Sarchielli P, Picconi B, Calabresi P (2008) Neuroinflammation and synaptic plasticity: Theoretical basis for a novel, immune-centered, therapeutic approach to neurological disorders. Trends Pharmacol Sci 29(8):402-412
31. Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P, Yen SH, Aronson MK (1992) Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 13:179-189
32. Duan J, Wainwright MS, Comeron JM, Saitou N, Sanders AR, Gelernter J, Gejman PV (2003) Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 12(3):205-216 (Pubitemid 36204418)
33. Efron B (1979) Bootstrap methods: Another look at the jackknife. Ann Stat 7(1):1-26
34. Egan MF, Goldberg TE, Kolachana BS et al (2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98 (12):6917-6922 (Pubitemid 32538317)
35. Elgersma Y, Silva AJ (1999) Molecular mechanisms of synaptic plasticity and memory. Curr Opin Neurobiol 9(2):209-213 (Pubitemid 29201794)
36. El-Ghundi M, O'Dowd BF, George SR (2007) Insights into the role of dopamine receptor systems in learning and memory. Rev Neurosci 18(1):37-66
37. Ernst T, Chang L, Jovicich J, Ames N, Arnold S (2002) Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients. Neurology 59(9):1343-1349 (Pubitemid 35285984)
38. Ernst T, Jiang CS, Nakama H, Buchthal S, Chang L (2010) Lower brain glutamate is associated with cognitive deficits in HIV patients: A new mechanism for HIV-Associated neurocognitive disorder. J Magn Reson Imaging 32(5):1045-1053
39. Everall I, Vaida F, Khanlou N, Lazzaretto D, Achim C, Letendre S et al (2009) Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J Neurovirol 15(5-6):360-370
40. Ferrarese C, Aliprandi A, Tremolizzo L et al (2001) Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology 57(4):671-675 (Pubitemid 32782996)
41. Floresco SB, Magyar O (2006) Mesocortical dopamine modulation of executive functions: Beyond working memory. Psychopharmacology (Berl) 188(4):567-585 (Pubitemid 46758962)
42. Garthwaite J, Boulton CL (1995) Nitric oxide signaling in the central nervous system. Annu Rev Physiol 57:683-706
43. Gaskill PJ, Calderon TM, Luers AJ, Eugenin EA, Javitch JA, Berman JW (2009) Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: A bridge between HIV-Associated neurologic disorders and drug abuse. Am J Pathol 175(3):1148-1159
44. Gelbard HA, Dewhurst S, Maggirwar SB, Kiebala M, Polesskaya O, Gendelman HE (2010) Rebuilding synaptic architecture in HIV-1 associated neurocognitive disease: A therapeutic strategy based on modulation of mixed lineage kinase. Neurotherapeutics 7(4):392-398
45. Gelman BB, Nguyen TP (2010) Synaptic proteins linked to HIV-1 infection and immunoproteasome induction: Proteomic analysis of human synaptosomes. J Neuroimmune Pharmacol 5(1):92-102
46. Gelman BB, Dholakia S, Casper K, Kent TA, Cloyd MW, Freeman D Jr (1996) Expansion of the cerebral ventricles and correlation with AIDS neuropathology in 232 patients. Arch Pathol Lab Med 120 (9):866-871 (Pubitemid 26326110)
47. Gelman BB, Soukup VM, Schuenke KW et al (2004) Acquired neuronal channelopathies in HIV-Associated dementia. J Neuroimmunol 157(1-2):111-119 (Pubitemid 39576644)
48. Gelman BB, Spencer JA, Holzer CE 3rd, Soukup VM (2006) Abnormal striatal dopaminergic synapses in National NeuroAIDS Tissue Consortium subjects with HIV encephalitis. J Neuroimmune Pharmacol 1:410-420 (Pubitemid 44786674)
49. Gerfen CR, Engber TM, Mahan LC et al (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250(4986):1429-1432 (Pubitemid 120031867)
50. Gerfen CR, McGinty JF, Young WS 3rd (1991) Dopamine differentially regulates dynorphin, Substance P, and enkephalin expression in striatal neurons: In situ hybridization histochemical analysis. J Neurosci 11(4):1016-1031
51. Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995) Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlations with dementia. Ann Neurol 38(5):755-762
52. Gobin SJ, van Zutphen M, Woltman AM, van den Elsen PJ (1999) Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element. J Immunol 163(3):1428-1434 (Pubitemid 29352763)
53. Goddard CA, Butts DA, Shatz CJ (2007) Regulation of CNS synapses by neuronalMHCclass I. Proc Natl Acad Sci USA 104(16):6628-6633
54. Goldman-Rakic PS (1996) Regional and cellular fractionation of working memory. Proc Natl Acad Sci USA 93(24):13473-13480 (Pubitemid 26424144)
55. Goldman-Rakic PS (1998) The cortical dopamine system: Role in memory and cognition. Adv Pharmacol 42:707-711
56. Goldstein RZ, Volkow ND (2002) Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159(10):1642-1652
57. Gulledge AT, Jaffe DB (1998) Dopamine decreases the excitability of layer V pyramidal cells in the rat prefrontal cortex. J Neurosci 18 (21):9139-9151 (Pubitemid 28491775)
58. Hadjilambreva G, Mix E, Rolfs A, Müller J, Strauss U (2005) Neuromodulation by a cytokine: Interferon-β differentially augments neocortical neuronal activity and excitability. J Neurophysiol 93 (2):843-852
59. Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C et al (2010) HIV-Associated neurocognitive disorders persist in the era of potent antiretroviral therapy. Neurology 75(23):2087-2096
60. Hille CJ, Fox SH, Maneuf YP, Crossman AR, Brotchi JM (2001) Antiparkinsonian action of a delta opioid agonist in rodent and primate models of Parkinson's disease. Exp Neurol 172(1):189-198 (Pubitemid 33143821)
61. Ho WZ, Douglas SD (2004) Substance P and neurokinin-1 receptor modulation of HIV. J Neuroimmunol 157(1):48-55 (Pubitemid 39576636)
62. Hobart M, Ramassar V, Goes N, Urmson J, Halloran PF (1997) IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo. J Immunol 158 (9):4260-4269 (Pubitemid 127483927)
63. Hriso E, Kuhn T, Masdeu JC, Grundman M (1991) Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy. Am J Psychiatry 148(11):1558-1561
64. Ito H, Kodaka F, Takahashi H et al (2011) Relation between presynaptic and postsynaptic dopaminergic functions measured by positron emission tomography: Implication of dopaminergic tone. J Neurosci 31(21):7886-7890
65. Jakubs K, Bonde S, Losif RE et al (2008) Inflammation regulates functional integration of neurons born in adult brain. J Neurosci 28(47):12477-12488
66. Jankowsky JL, Patterson PH (1999) Cytokine and growth factor involvement in long-Term potentiation. Mol Cell Neurosci 14 (6):273-286 (Pubitemid 29506159)
67. Kaul M, Lipton SA (2006) Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS. J Neuroimmune Pharmacol 1(2):138-151 (Pubitemid 44257489)
68. Kawasaki Y, Zhang L, Cheng JK, Ji RR (2008) Cytokine mechanisms of central sensitization: Distinct and overlapping role of interleukin-1β interleukin-6, and tumor necrosis factor-α in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 28 (20):5189-5194
69. Kellendonk C, Simpson EH, Polan HJ et al (2006) Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49(4):603-615 (Pubitemid 43221894)
70. Kennedy SE, Koeppe RA, Young EA, Zubieta JK (2006) Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. Arch Gen Psychiatry 63(11):1199-1208 (Pubitemid 44708077)
71. Khairova RA, Machado-Vieiraa R, Du J, Manjia HK (2009) A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol 12(4):561-578
72. Kim IJ, Beck HN, Lein PJ, Higgins D (2002) Interferon gamma induces retrograde dendritic retraction and inhibits synapse formation. J Neurosci 22(11):4530-4539 (Pubitemid 37465669)
73. Koutsilieri E, Czub S, Scheller C, Sopper S, Tatschner T, Stahl-Hennig C, ter Meulen V, Riederer P (2000) Brain choline acetyltransferase reduction in SIV infection. An index of early dementia? Neuroreport 11(11):2391-2393 (Pubitemid 30622277)
74. Koutsilieri E, Scheller C, Sopper S, Gotz ME, Gerlach M, Meulen V, Riederer P (2001a) Selegiline completely restores choline acetyltransferase activity deficits in simian immunodeficiency infection. Eur J Pharmacol 411(1-2):R1-R2 (Pubitemid 32013130)
75. Koutsilieri E, ter Meulen V, Riederer P (2001b) Neurotransmission in HIV associated dementia: A short review. J Neural Transm 108 (6):767-775 (Pubitemid 32662418)
76. Kovács GL, De Wied DD (1994) Peptidergic modulation of learning and memory processes. Pharmacol Rev 46(3):269-291 (Pubitemid 24310131)
77. Kroener S, Chandler LJ, Phillips PE, Seamans JK (2009) Dopamine modulates persistent synaptic activity and enhances the signal-To-noise ratio in the prefrontal cortex. PLoS One 4(8): E6507
78. Lidow MS, Wang F, Cao Y, Goldman-Rakic PS (1998) Layer V neurons bear the majority of mRNAs encoding the five distinct dopamine receptor subtypes in the primate prefrontal cortex. Synapse 28(1):10-20 (Pubitemid 128770598)
79. Low KG, Allen RG, Melner MH (1992) Differential regulation of proenkephalin expression in astrocytes by cytokines. Endocrinology 131(4):1908-1914
80. Maher FO, Clarke RM, Kelly A, Nally RE, Lynch MA (2006) Interaction between interferon gamma and insulin-like growth factor-1 in hippocampus impacts on the ability of rats to sustain long-Term potentiation. J Neurochem 96(6):1560-1571 (Pubitemid 43351616)
81. Malenka RC, Nicoll RA (1993) NMDA-receptor-dependent synaptic plasticity: Multiple forms and mechanisms. Trends Neurosci 16 (12):521-527 (Pubitemid 23341961)
82. Manéglier B, Guillemin GJ, Clayette P et al (2008) Serotonin decreases HIV-1 replication in primary cultures of human macrophages through 5-HT1A receptors. Br J Pharmacol 154(1):174-182 (Pubitemid 351620406)
83. Mansour A, Thompson RC, Akil H, Watson SJ (1993) Delta opioid receptor mRNA distribution in the brain: Comparison to delta receptor binding and proenkephalin. J Chem Neuroanat 6 (6):351-362 (Pubitemid 24034302)
84. Martin E, Nathan C, Xie QW (1994) Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med 180 (2):977-984 (Pubitemid 24256610)
85. Masliah E, Heaton RK, Marcotte TD et al (1997) Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. Ann Neurol 42(6):963-972 (Pubitemid 28008427)
86. Masliah E, DeTeresa RM, Mallory ME, Hansen LA (2000) Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS 14(1):69-74 (Pubitemid 30072079)
87. Masliah E, Roberts ES, Langford D et al (2004) Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis. J Neuroimmunol 157(1-2):163-175 (Pubitemid 39576651)
88. McArthur JC, Steiner J, Sacktor N, Nath A (2010) Human immunodeficiency virus-Associated neurocognitive disorders: Mind the gap. Ann Neurol 67(6):699-714
89. McGinty JF, Van der Kooy D, Bloom FE (1984) The distribution and morphology of opioid peptide immunoreactive neurons in the cerebral cortex of rats. J Neurosci 4(4):1104-1117 (Pubitemid 14146839)
90. Meisner F, Scheller C, Kneitz S, Sopper S, Neuen-Jacob E, Riederer P, ter Meulen V, Koutsilieri E (2008) Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: A novel pharmacological action of memantine. Neuropsychopharmacology 33(9):2228-2236 (Pubitemid 351992085)
91. Melrose RJ, Tinaz S, Castelo JM, Courtney MG, Stern CE (2008) Compromised fronto-striatal functioning in HIV: An fMRI investigation of semantic event sequencing. Behav Brain Res 188 (2):337-347
92. Mendoza-Fernández V, Andrew RD, Barajas-López C (2000) Interferon-α inhibits long-Term potentiation and unmasks a long-Term depression in the rat hippocampus. Brain Res 885 (1):14-24
93. Meyerhoff DJ, Bloomer C, Cardenas V, Norman D, Weiner MW, Fein G (1999) Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients. Neurology 52(5):995-1003 (Pubitemid 29161610)
94. Mizuno T, Zhang G, Takeuchi H et al (2008) Interferon-γ directly induces neurotoxicity through a neuron specific, calciumpermeable complex of IFN-γ receptor and AMPA GluR1 receptor. FASEB J 22(6):1797-1806 (Pubitemid 351811457)
95. Monte-Silva K, Kuo MF, Thirugnanasambandam N, Liebetanz D, Paulus W, Nitsche MA (2009) Dose-dependent inverted Ushaped effect of dopamine (D2-like) receptor activation on focal and nonfocal plasticity in humans. J Neurosci 29(19):6124-6131
96. Morgello S, Gelman BB, Kozlowski P, Vinters H (2001) The national neuroAIDS tissue consortium: A new paradigm in brain banking with an emphasis on infectious disease. Neuropathol Appl Neurobiol 27(4):326-335 (Pubitemid 32758619)
97. Morgello S, Holzer CE 3rd, Ryan E, Young C, Naseer M, Castellon SA, Frol AB, Atkinson JH, Gelman BB, Grant I, Singer EJ (2006) Inter-rater reliability of the psychiatric research interview for substance and mental disorders in an HIV-infected cohort: Experience of the national neuroAIDS tissue consortium. Int J Methods Psychiatr Res 15(3):131-138 (Pubitemid 47047004)
98. Morris BJ, Hunt SP (1991) Proenkephalin mRNA levels in rat striatum are increased and decreased, respectively, by selective D2 and D1 dopamine receptor antagonists. Neurosci Lett 125(2):201-204
99. Murray MF (2003) Tryptophan depletion and HIV infection: A metabolic link to pathogenesis. Lancet Infect Dis 3:644-652 (Pubitemid 37210228)
100. Nagano-Saito A, Leyton M, Monchi O, Goldberg YK, He Y, Dagher A (2008) Dopamine depletion impairs frontostriatal functional connectivity during a set-shifting task. J Neurosci 28(14):3697-3706
101. Nath A, Anderson C, Jones M et al (2000) Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J Psychopharmacol 14(3):222-227
102. Nath A, Hauser KF, Wojna V et al (2002) Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr 31(2):S62-S69 (Pubitemid 35190560)
103. Negro A, Tavella A, Facci L, Callegaro L, Skaper SD (1992) Interleukin-1 beta regulates proenkephalin gene expression in astrocytes cultured from rat cortex. Glia 6(3):206-212
104. Neumann H, Schmidt H, Cavalié A, Jenne D, Wekerle H (1997) Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: Differential regulation by interferon (IFN)-γ and tumor necrosis factor (TNF)-α. J Exp Med 185(2):305-316 (Pubitemid 27078287)
105. Nguyen TN, Soukup VM, Gelman BB (2010) Persistent hijacking of brain proteasomes in HIV-Associated dementia. Am J Pathol 176 (2):893-902
106. O'Connor JJ, Coogan AN (1999) Actions of the pro-inflammatory cytokine IL-1 beta on central synaptic transmission. Exp Physiol 84(4):601-614 (Pubitemid 29401719)
107. Otani S, Daniel H, Roisin MP, Crepel F (2003) Dopaminergic modulation of long-Term synaptic plasticity in rat prefrontal neurons. Cerebr Cortex 13(11):1251-1256 (Pubitemid 37323001)
108. Ottowitz WE, Dougherty DD, Savage CR (2002) The neural network basis for abnormalities of attention and executive function in major depressive disorder: Implications for application of the medical disease model to psychiatric disorders. Harvard Rev Psychiatry 10(2):86-99 (Pubitemid 34263979)
109. Ovadia H, Magenheim Y, Behar O, Rosen H (1996) Molecular characterization of immune derived proenkephalin mRNA and the involvement of the adrenergic system in its expression in rat lymphoid cells. J Neuroimmunol 68(1-2):77-83 (Pubitemid 26279249)
110. Palmer S, Wiegand AP, Maldarelli F et al (2003) New real-Time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 41(10):4531-4536 (Pubitemid 37259753)
111. Parks RW, Loewenstein DA, Dodrill KL et al (1988) Cerebral metabolic effects of a verbal fluency test: A PET scan study. J Clin Exp Neuropsychol 10(5):565-575
112. Peckys D, Hurd YL (2001) Prodynorphin and κ opioid receptor mRNA expression in the cingulate and prefrontal cortices of subjects diagnosed with schizophrenia or affective disorders. Brain Research Bull 55(5):619-624 (Pubitemid 32888380)
113. Przewłocka B, Lasoń W(1995) Adaptive changes in the proenkephalin and D2 dopamine receptor mRNA expression after chronic cocaine in the nucleus accumbens and striatum of the rat. Eur Neuropsychopharmacol 5(4):465-469
114. Ross FM, Allan SM, Rothwell NJ, Verkhratsky A (2003) A dual role for interleukin-1 in LTP in mouse hippocampal slices. J Neuroimmunology 144(1-2):61-67 (Pubitemid 37329930)
115. Sarter M, Podell M (2000) Preclinical psychopharmacology of AIDSassociated dementia: Lessons to be learned from the cognitive psychopharmacology of other dementias. J Psychopharmacol 14 (3):197-204
116. Sas AR, Bimonte-Nelson H, Smothers CT, Woodward J, Tyor WR (2009) Interferon-α causes neuronal dysfunction in encephalitis. J Neurosci 29(12):3948-3955
117. Sawaguchi T, Matsumura M, Kubota K (1990) Effects of dopamine antagonists on neuronal activity related to a delayed response task in monkey prefrontal cortex. J Neurophysiol 63(6):1401-1412 (Pubitemid 20217476)
118. Schlosser R, Hutchinson M, Joseffer S et al (1998) Functional magnetic resonance imaging of human brain activity in a verbal fluency task. J Neurol Neurosurg Psychiatry 64(4):492-498 (Pubitemid 28195951)
119. Schroecksnadel K, Zangerle R, Bellmann-Weiler R et al (2007) Indoleamine-2, 3-dioxygenase and other interferon-gammamediated pathways in patients with human immunodeficiency virus infection. Curr Drug Metab 8(3):225-236 (Pubitemid 46621672)
120. Seamans JK, Yang CR (2004) The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 74(1):1-58
121. Sesack SR, Carr DB (2002) Selective prefrontal cortex inputs to dopamine cells: Implications for schizophrenia. Physiol Behav 77(4-5):513-517 (Pubitemid 36084394)
122. Squire LR, Zola-Morgan S (1991) The medial temporal lobe memory system. Science 253(5026):1380-1386 (Pubitemid 21917285)
123. Steiner H, Gerfen CR (1999) Enkephalin regulates acute D2 dopamine receptor antagonist-induced immediate-early gene expression in striatal neurons. Neuroscience 88(3):795-810 (Pubitemid 28518258)
124. Steinmetz CC, Turrigian GG (2010) Tumor necrosis factor-α signaling maintains the ability of cortical synapses to express synaptic scaling. J Neurosci 30(44):14685-14690
125. Stellwagen D, Malenka RC (2006) Synaptic scaling mediated by glial TNF-α. Nature 440(7087):1054-1059
126. Tancredi V, D'Arcangelo G, Grassi F, Tarronic P, Palmieri G, Santoni A, Eusebi F (1992) Tumor necrosis factor alters synaptic transmission in rat hippocampal slices. Neurosci Lett 146(2):176-178
127. Theofilopoulos AN, Baccala R, Beutler B, Kono DH (2005) Type I interferons (α/β) in immunity and autoimmunity. Annu Rev Immunol 23:307-336
128. Tierney PL, Thierry AM, Glowinski J, Deniau JM, Gioanni Y (2008) Dopamine modulates temporal dynamics of feedforward inhibition in rat prefrontal cortex in vivo. Cereb Cortex 18(10):2251-2262
129. Trantham-Davidson H, Neely LC, Lavin A, Seamans JK (2004) Mechanisms underlying differential D1 versus D2 dopamine receptor regulation of inhibition in prefrontal cortex. J Neurosci 24(47):10652-10659 (Pubitemid 39557638)
130. Tremblay LK, Naranjo CA, Graham SJ et al (2005) Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry 62(11):1228-1236 (Pubitemid 41586922)
131. van der Werf-Eldering MJ, Burger H, Holthausen EAE, Aleman A, Nolen WA (2010) Cognitive functioning in patients with bipolar disorder: Association with depressive symptoms and alcohol use. PLoS ONE 5(9):e13032. doi:10.1371/journal. pone.0013032
132. Verdejo A, Toribiob I, Orozcoa C, Puentec KL, Pérez-Garcíaa M (2005) Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers. Drug Alcohol Depend 78 (3):283-288 (Pubitemid 40694050)
133. Victório SC, Havton LA, Oliveira AL (2010) Absence of IFNγ expression induces neuronal degeneration in the spinal cord of adult mice. J Neuroinflammation 7:77. doi:10.1186/1742-2094-7-77
134. Vikman KS, Owe-Larsson B, Brask J et al (2001) Interferon-gammainduced changes in synaptic activity and AMPA receptor clustering in hippocampal cultures. Brain Res 896(1-2):18-29 (Pubitemid 32244142)
135. Volkow NC, Fowler JS,Wang GJ (1999) Imaging studies on the role of dopamine in cocaine reinforcement with addiction in humans. J Psychopharmacology 13:337-345 (Pubitemid 30055177)
136. Volkow N, Logan J, Fowler J, Wang G, Gur R, Wong C, Felder C, Gatley S, Ding Y, Hitzmann R, Pappas N (2000) Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. Am J Psychiatry 157:75-80 (Pubitemid 30027424)
137. Wang GJ, Chang L, Volkow ND et al (2004a) Decreased brain dopaminergic transporters in HIV-Associated dementia patients. Brain 127(11):2452-2458 (Pubitemid 39472973)
138. Wang M, Vijayraghavan S, Goldman-Rakic PS (2004b) Selective D2 receptor actions on the functional circuitry of working memory. Science 303(5659):853-856 (Pubitemid 38174667)
139. Wetzel MA, Steele AD, Eisenstein TK et al (2000) μ-opioid induction of monocyte chemoattractant protein-1, RANTES, and IFN-γ-inducible protein-10 expression in human peripheral blood mononuclear cells. J Immunol 165(11):6519-6524
140. Wiley CA, Achim CL (1994) Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol 36(4):673-676
141. Wilkinson LS (1997) The nature of interactions involving prefrontal and striatal dopamine systems. J Psychopharmacol 11:143-150 (Pubitemid 27252645)
142. Wolf ME (2002) Addiction: Making the connection between behavioral changes and neuronal plasticity in specific pathways. Mol Interv 2 (3):146-157
143. Woods SP, Conover E, Rippeth JD et al (2004) Qualitative aspects of verbal fluency in HIV-Associated dementia: A deficit in ruleguided lexical-semantic search processes? Neuropsychologia 42 (6):801-809 (Pubitemid 38230209)
144. Woods SP, Moore DJ, Weber E, Grant I (2009) Cognitive neuropsychology of HIV-Associated neurocognitive disorders. Neuropsychol Rev 19(2):152-168
145. Xie CW, Lewis DV (1995) Endogenous opioids regulate long-Term potentiation of synaptic inhibition in the dentate gyrus of rat hippocampus. J Neurosci 15(5pt2):3788-3795
146. Yirmiya R, Goshen I (2011) Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun 25 (2):181-213
147. Zhang Y, Bertolino A, Fazio L et al (2007) Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci USA 104(51):20552-20557
148. Zhu J, Ananthan S, Mactutus CF, Booze R (2011) Recombinant human immunodeficiency virus-1 transactivator of transcription1-86 allosterically modulates dopamine. Synapse 65:1251-1254